The differential effects of formalin fixation on DNA and RNA quality present a challenge in optimizing sample preparation for thyroid cancer genomic analysis, where both DNA-based (e.g., BRAF V600E mutations) and RNA-based (e.g., RET and NTRK fusion genes) analyses are crucial. This evidence concerns the gene BRAF and thyroid cancer.